4.7 Article

Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections

Related references

Note: Only part of the references are listed.
Article Immunology

Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN

Ritu Banerjee et al.

Summary: The study demonstrated that rapid organism identification and phenotypic AST can lead to faster antibiotic therapy adjustments for patients with gram-negative bloodstream infections (BSIs), ultimately improving treatment outcomes.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial

J-H Kim et al.

Summary: The study found that antimicrobial stewardship programmes based on rapid phenotypic AST can significantly increase the proportion of patients with haematological malignancies receiving optimal targeted antibiotics and shorten the time to treatment.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes

A. Quirino et al.

Summary: Antimicrobial Susceptibility Testing is crucial for managing Bloodstream Infections to determine the appropriate antimicrobial therapy. This new approach of obtaining AST results directly from positive blood cultures using Microscan WA enables rapid identification of antibiotic resistance profiles, leading to time reduction compared to traditional methods.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Article Immunology

Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?

Evan D. Robinson et al.

Summary: This study found that implementation of a phenotypic RDT + ASP intervention can reduce the time to antimicrobial susceptibility testing and institutional-preferred antimicrobial therapy for patients with Gram-negative bacilli bloodstream infections. It also showed a decrease in the use of broad-spectrum agents and an increase in narrow-spectrum beta-lactams. Although discrepant RDT results occurred, there were no differences in clinical outcomes observed.

CLINICAL INFECTIOUS DISEASES (2021)

Review Microbiology

Innovative and rapid antimicrobial susceptibility testing systems

Alex van Belkum et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Article Infectious Diseases

EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories

Anna Akerlund et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Article Critical Care Medicine

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Andrew Rhodes et al.

INTENSIVE CARE MEDICINE (2017)

Article Medicine, General & Internal

Time to Treatment and Mortality during Mandated Emergency Care for Sepsis

Christopher W. Seymour et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Critical Care Medicine

The Timing of Early Antibiotics and Hospital Mortality in Sepsis

Vincent X. Liu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Infectious Diseases

Clinical characteristics and outcome of elderly patients with community-onset bacteremia

Cristina Hernandez et al.

JOURNAL OF INFECTION (2015)

Editorial Material Microbiology

The Value of Outcomes Data in the Practice of Clinical Microbiology

Gary V. Doern

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Article Immunology

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices

James H. Jorgensen et al.

CLINICAL INFECTIOUS DISEASES (2009)

Article Microbiology

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay

Kimberly K. Scarsi et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)